Is BBNX or INMD more profitable?

INMD runs the higher net margin — BBNX at -61.32% versus INMD at 20.69%.

Beta Bionics, Inc. (BBNX) vs InMode Ltd. (INMD)

A side-by-side comparison of Beta Bionics, Inc. and InMode Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BBNX

Beta Bionics, Inc.

$838M

$18.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

INMD

InMode Ltd.

$804M

$13.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BBNX vs INMD

growth of $100 · dividends reinvested · last 2y

BBNX -19.8% (-10.4%/yr)INMD -18.8% (-9.9%/yr)INMD compounded faster over this window

BBNX INMD

BBNX vs INMD: by the numbers

•BBNX is the larger company ($838M vs $804M market cap).
•INMD is profitable (20.69% net margin) while BBNX runs a net loss (-61.32%).

Metrics side by side

Valuation

Metric	BBNX	INMD
P/E ratio	N/A	11.37
Forward P/E	N/A	10.79
PEG ratio	N/A	1.14
P/S ratio	7.04	2.15
P/B ratio	3.27	1.28
EV / EBITDA	N/A	5.90
FCF yield	N/A	10.88%

Profitability

Metric	BBNX	INMD
Gross margin	58.31%	76.52%
Operating margin	-69.75%	18.47%
Net margin	-61.32%	20.69%
ROE	-28.46%	12.32%
ROIC	-31.17%	9.20%

Growth (annualized)

Metric	BBNX	INMD
Revenue CAGR (5Y)	N/A	5.42%
EPS CAGR (5Y)	N/A	6.87%
FCF CAGR (5Y)	N/A	1.36%
Total return CAGR (5Y)	N/A	-27.48%

Frequently asked

Is BBNX or INMD more profitable?: INMD runs the higher net margin — BBNX at -61.32% versus INMD at 20.69%.

Go deeper

Full BBNX analysis Full INMD analysis Interactive comparison tool

Dig into the metrics

InMode P/E ratio Beta Bionics ROE InMode ROE Beta Bionics operating margin InMode operating margin Beta Bionics revenue growth InMode revenue growth Beta Bionics free cash flow InMode free cash flow

Beta Bionics & InMode appear in these rankings

Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.